IVIGENE CORP has a total of 12 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, New Zealand and United States. Its main competitors in its focus markets biotechnology and organic fine chemistry are SMALL MOLECULE THERAPEUTICS IN, BEIJING TUBERCULOSIS AND THORACIC TUMOR RES INST and VAZYME BIOTECH NANJING CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | New Zealand | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Measuring microorganism processes | |
#3 | Combinatorial chemistry | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Hillman Jeffrey D | 9 |
#2 | Progulske-Fox Ann | 5 |
#3 | Handfield Martin | 5 |
#4 | Brady L Jeannine | 4 |
#5 | Hillman Jeffrey Daniel | 2 |
#6 | Brady Jeannine L | 1 |
Publication | Filing date | Title |
---|---|---|
AU2003230557A1 | In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization | |
US2002197625A1 | Identification of microbial polynucleotides expressed during infection of a host | |
MXPA01012787A | Microbial polynucleotides expressed during infection of a host. |